{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:52:10Z","timestamp":1779306730997,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2019-109240RB-I00"],"award-info":[{"award-number":["PID2019-109240RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2020-118511RB-I00"],"award-info":[{"award-number":["PID2020-118511RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017SGR1604"],"award-info":[{"award-number":["2017SGR1604"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Generalitat de Catalunya Agencia de Gestio d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013248","name":"Family Process Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000493"],"award-info":[{"award-number":["ZIA DA000493"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114327","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T23:25:14Z","timestamp":1675207514000},"page":"114327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization"],"prefix":"10.1016","volume":"160","author":[{"given":"Marta","family":"Valle-Le\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil","family":"Casajuana-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Llinas","family":"del Torrent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Argerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"G\u00f3mez-Acero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Sahlholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-3739","authenticated-orcid":false,"given":"Francisco","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114327_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2023.114327_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2009.01.005","article-title":"The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice","volume":"79","author":"L\u00f3pez-Mu\u00f1oz","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2023.114327_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-642-25761-2_4","article-title":"Serotonergic mechanisms as targets for existing and novel antipsychotics","author":"Meltzer","year":"2012","journal-title":"Handb. Exp. Pharm. Handb. Exp. Pharm."},{"key":"10.1016\/j.biopha.2023.114327_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114327_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114327_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.biopha.2023.114327_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.biopha.2023.114327_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/wps.20579","article-title":"Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis","volume":"17","author":"Carbon","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.biopha.2023.114327_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114327_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0269881119862535","article-title":"Clozapine and tardive dyskinesia in patients with schizophrenia: a systematic review","volume":"33","author":"Pardis","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2023.114327_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-015-0278-3","article-title":"Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism","volume":"29","author":"de Bartolomeis","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2023.114327_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114327_bib13","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/ -arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2023.114327_bib14","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of \u03b2-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2023.114327_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.23402","article-title":"Tardive dyskinesia and other movement disorders secondary to aripiprazole","volume":"26","author":"Pe\u00f1a","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2023.114327_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/JCP.0000000000000543","article-title":"Risk of extrapyramidal adverse events with aripiprazole","volume":"36","author":"Etminan","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2023.114327_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/NRL.0000000000000096","article-title":"Movement disorders induced by the \u201catypical\u201d antipsychotic aripiprazole","volume":"22","author":"Selfani","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.biopha.2023.114327_bib18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1021\/acschembio.8b00168","article-title":"Functionally biased D2R antagonists: targeting the \u03b2-arrestin pathway to improve antipsychotic treatment","volume":"13","author":"We\u00efwer","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biopha.2023.114327_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114327_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.euroneuro.2016.01.001","article-title":"The fast-off hypothesis revisited: a functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor","volume":"26","author":"Sahlholm","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2023.114327_bib21","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1507704112","article-title":"Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer","volume":"112","author":"Bonaventura","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2023.114327_bib22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41467-018-03522-3","article-title":"Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase","volume":"9","author":"Navarro","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114327_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107977","article-title":"G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)","volume":"231","author":"Ferr\u00e9","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114327_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2011.01.022","article-title":"On the existence of a possible A2A-D2-\u03b2-arrestin2 complex: A2A agonist modulation of D2 agonist-induced \u03b2-arrestin2 recruitment","volume":"406","author":"Borroto-Escuela","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114327_bib25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/aps.2013.87","article-title":"Modulation of A2a receptor antagonist on D2 receptor internalization and ERK phosphorylation","volume":"34","author":"Huang","year":"2013","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2023.114327_bib26","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1007\/s12035-017-0696-y","article-title":"Antipsychotic-like efficacy of dopamine D2 receptor-biased ligands is dependent on adenosine A2A receptor expression","volume":"55","author":"Sahlholm","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2023.114327_bib27","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4155\/fmc-2018-0335","article-title":"Dopamine receptor heteromers: biasing antipsychotics","volume":"10","author":"Sahlholm","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.biopha.2023.114327_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(94)90551-7","article-title":"KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity","volume":"256","author":"Kanda","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114327_bib29","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1073\/pnas.98.4.1970","article-title":"The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice","volume":"98","author":"Chen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biopha.2023.114327_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00001756-200104170-00024","article-title":"Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy","volume":"12","author":"el Yacoubi","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2023.114327_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12432","article-title":"Behavioral control by striatal adenosine A2A-dopamine D2 receptor heteromers","volume":"17","author":"Taura","year":"2018","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.biopha.2023.114327_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2013.03.035","article-title":"Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: Studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice","volume":"247","author":"Pardo","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2023.114327_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0893-133X(97)00033-X","article-title":"Adenosine A2A agonists: a potential new type of atypical antipsychotic","volume":"17","author":"Rimondini","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s002130100777","article-title":"The adenosine A2A agonist CGS 21680 reverses the reduction in prepulse inhibition of the acoustic startle response induced by phencyclidine, but not by apomorphine and amphetamine","volume":"156","author":"Sills","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-4328(03)00036-6","article-title":"Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor","volume":"143","author":"Wang","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2023.114327_bib36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41386-020-00872-9","article-title":"Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia","volume":"46","author":"Valle-Le\u00f3n","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0893-133X(98)00051-7","article-title":"Involvement of adenosine A(2A) receptors in the induction of c-fos expression by clozapine and haloperidol","volume":"20","author":"Pinna","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(97)00564-8","article-title":"Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity","volume":"232","author":"\u00d6gren","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2023.114327_bib39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/41771","article-title":"Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor","volume":"388","author":"Ledent","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.114327_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ilar.38.1.41","article-title":"Special report: the 1996 guide for the care and use of laboratory animals","author":"Clark","year":"1997","journal-title":"ILAR J. Natl. Res. Council Inst. Lab. Anim. Resour."},{"key":"10.1016\/j.biopha.2023.114327_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-1-4939-8576-0_15","article-title":"Assessing GPCR dimerization in living cells: comparison of the NanoBiT assay with related bioluminescence- and fluorescence-based approaches","volume":"140","author":"Wouters","year":"2018","journal-title":"Neuromethods"},{"key":"10.1016\/j.biopha.2023.114327_bib42","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/hmg\/ddy264","article-title":"Metabotropic glutamate type 5 receptor requires contactin-associated protein 1 to control memory formation","volume":"27","author":"Morat\u00f3","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2023.114327_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-418687-3.00018-5","article-title":"Transient mammalian cell transfection with polyethylenimine (PEI)","volume":"529","author":"Longo","year":"2013","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2023.114327_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113896","article-title":"The ADORA1 mutation linked to early-onset Parkinson\u2019s disease alters adenosine A1-A2A receptor heteromer formation and function","volume":"156","author":"Sarasola","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114327_bib45","doi-asserted-by":"crossref","first-page":"37545","DOI":"10.1074\/jbc.M302809200","article-title":"The adenosine A2A receptor interacts with the actin-binding protein \u03b1-actinin","volume":"278","author":"Burgue\u00f1o","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114327_bib46","doi-asserted-by":"crossref","unstructured":"X. Morat\u00f3, D.O. Borroto-Escuela, K. Fuxe, V. Fern\u00e1ndez-Due\u00f1as, F. Ciruela, Co. -immunoprecipitation brain 2021 doi:\u00a010.1007\/978-1-4939-3064-7_2.","DOI":"10.1007\/978-1-0716-1522-5_2"},{"key":"10.1016\/j.biopha.2023.114327_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14884-y","article-title":"Haloperidol bound D 2 dopamine receptor structure inspired the discovery of subtype selective ligands","volume":"11","author":"Fan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114327_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nsmb.2504","article-title":"Crystal structure of oligomeric \u03b21-adrenergic G protein-coupled receptors in ligand-free basal state","volume":"20","author":"Huang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114327_bib49","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/acs.jmedchem.6b00653","article-title":"Controlling the dissociation of ligands from the adenosine A2A receptor through modulation of salt bridge strength","volume":"59","author":"Segala","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114327_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature25758","article-title":"Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone","volume":"555","author":"Wang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.114327_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20221-0","article-title":"Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone","volume":"11","author":"Im","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114327_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT 2A receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"Kimura","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2010","key":"10.1016\/j.biopha.2023.114327_bib53","first-page":"1091","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"Chien","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.114327_bib54","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.9b00269","article-title":"PACKMOL-memgen: a simple-to-use, generalized workflow for membrane-protein-lipid-bilayer system building","volume":"59","author":"Schott-Verdugo","year":"2019","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.biopha.2023.114327_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"2","author":"Abraham","year":"2015","journal-title":"SoftwareX 1"},{"key":"10.1016\/j.biopha.2023.114327_bib56","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.csbj.2020.09.028","article-title":"Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A2A receptor","volume":"18","author":"Navarro","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.biopha.2023.114327_bib57","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2023.114327_bib58","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein-protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2023.114327_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.biopha.2023.114327_bib60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","article-title":"Therapeutic drug monitoring of common antipsychotics","volume":"34","author":"Patteet","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.biopha.2023.114327_bib61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(24)36475-4","article-title":"Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs","volume":"280","author":"Florijn","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114327_bib62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)37099-5","article-title":"Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs","volume":"283","author":"Lidow","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114327_bib63","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0306-4522(96)00631-8","article-title":"Differential regulation of dopamine receptors after chronic typical and a typical antipsychotic drug treatment","volume":"78","author":"Tarazi","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2023.114327_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00210-010-0577-7","article-title":"Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization","volume":"383","author":"Koener","year":"2011","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2023.114327_bib65","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/schbul\/sbr006","article-title":"Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis","volume":"38","author":"Tadokoro","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.biopha.2023.114327_bib66","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1074\/jbc.RA118.004682","article-title":"The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface","volume":"294","author":"Schrader","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114327_bib67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2013.01.008","article-title":"The dynamic process of \u03b2(2)-adrenergic receptor activation","volume":"152","author":"Nygaard","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114327_bib68","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/schbul\/sbaa038","article-title":"Altered signaling in CB1R-5-HT2AR heteromers in olfactory neuroepithelium cells of schizophrenia patients is modulated by cannabis use","volume":"46","author":"Guinart","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.biopha.2023.114327_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2379-5","article-title":"Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane","volume":"584","author":"Yin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.114327_bib70","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","article-title":"Structural insights into the human D1 and D2 dopamine receptor signaling complexes","volume":"184","author":"Zhuang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114327_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52189","article-title":"Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism","volume":"9","author":"Lane","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2023.114327_bib72","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s002130000532","article-title":"Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study","volume":"152","author":"Silvestri","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib73","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"\u201cBreakthrough\u201d dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114327_bib74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.psychres.2015.02.021","article-title":"Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia","volume":"227","author":"Suzuki","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.biopha.2023.114327_bib75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02245329","article-title":"Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum","volume":"116","author":"Ferr\u00e9","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib76","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00213-016-4212-2","article-title":"Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders","volume":"233","author":"Ferr\u00e9","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2023.114327_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"K\u00f6falvi","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2023.114327_bib78","article-title":"Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation","author":"Donthamsetti","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2023.114327_bib79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2023.114327_bib80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","article-title":"Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson\u2019s disease","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biopha.2023.114327_bib81","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: orientations of proteins in membranes database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:49:37Z","timestamp":1776772177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":81,"alternative-id":["S0753332223001154"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114327","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114327"}}